[Congenital generalized lipodystrophy]

Paulo P Figueiredo Filho1, Alexandre Costa Val, Rosângela Diamante

  • 1Dep. de Pediatria, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG.

Jornal De Pediatria
|August 17, 2004
PubMed

Insights

Congenital generalized lipodystrophy presents with muscle hypertrophy and lipoatrophy. Understanding this rare syndrome highlights adipose tissue

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Disorders

Context:

  • Congenital generalized lipodystrophy (CGL) is a rare genetic disorder.
  • Characterized by a near-complete absence of adipose tissue.
  • Impacts multiple metabolic processes.

Purpose:

  • To detail the clinical and biochemical features of CGL.
  • To aid in the diagnosis of this unusual syndrome.

Summary:

  • Eight infants with CGL exhibited muscle hypertrophy, generalized lipoatrophy, and acromegalic appearance.
  • Common findings included acanthosis nigricans, hepatosplenomegaly, hypertriglyceridemia, and low HDL cholesterol.
  • Two patients developed diabetes mellitus; one had cardiac hypertrophy.

Impact:

  • Phenotypic characteristics of CGL are well-defined, facilitating clinical diagnosis.
  • CGL underscores the critical role of adipose tissue in metabolic regulation.
  • Insights from CGL may advance research into common diseases like diabetes and obesity.
Abstract

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...